HARMONY BIOSCIENCES HOLDINGS, INC. Tax Withholding Paid on Stock Awards
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) reported Tax Withholding Paid on Stock Awards of $3.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-04
- HARMONY BIOSCIENCES HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $1.07M, a 4.07% increase year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $2.56M, a 96.10% increase year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $663.00K, a 70.24% decline year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $0.00.
- HARMONY BIOSCIENCES HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $3.00M, a 20.30% increase from fiscal 2024.
- HARMONY BIOSCIENCES HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $2.50M, a 385.80% increase from fiscal 2023.
- HARMONY BIOSCIENCES HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $514.00K.
- HARMONY BIOSCIENCES HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2020 was $17.00K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $3.64M 10-Q · filed 2026-08-04 | $4.30M derived: sum of 3 quarters · filed 2026-08-04 | $4.30M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $2.56M 10-Q · filed 2026-05-07 | $3.23M derived: sum of 2 quarters · filed 2026-05-07 | $3.23M derived: sum of 3 quarters · filed 2026-05-07 | $4.26M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $663.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $663.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.70M derived: sum of 3 quarters · filed 2026-08-04 | $3.00M 10-K · filed 2026-02-24 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.03M derived: sum of 2 quarters · filed 2026-08-04 | $2.34M 10-Q · filed 2025-11-04 | $4.57M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.34M 10-Q · filed 2026-08-04 | $4.57M derived: sum of 3 quarters · filed 2026-08-04 | $4.57M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $1.31M 10-Q · filed 2026-05-07 | $3.54M derived: sum of 2 quarters · filed 2026-05-07 | $3.54M derived: sum of 3 quarters · filed 2026-05-07 | |
| 2024-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.23M derived: sum of 2 quarters · filed 2026-02-24 | $2.50M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $269.00K 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $269.00K 10-Q · filed 2025-08-05 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $514.00K 10-K · filed 2026-02-24 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $514.00K 10-Q · filed 2024-10-29 | ||
| 2023-06-30 | $514.00K 10-Q · filed 2024-08-06 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $17.00K 10-K · filed 2023-02-21 | ||
| 2020-09-30 | $17.00K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |